Kunming Longjin Pharmaceutical Co., Ltd. (SHE:002750)

Market Cap	236.30M
Revenue (ttm)	45.99M
Net Income (ttm)	-41.03M
Shares Out	400.50M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,729,830
Average Volume	14,741,678
Open	0.6000
Previous Close	0.5700
Day's Range	0.5700 - 0.6300
52-Week Range	0.5600 - 3.1200
Beta	0.21
RSI	19.28
Earnings Date	Aug 28, 2025

About SHE:002750

Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business. Kunming Longjin Pharmaceutical Co., Ltd. was founded in 1996 and i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 188
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002750

Financial Performance

In 2024, SHE:002750's revenue was 66.48 million, a decrease of -23.25% compared to the previous year's 86.62 million. Losses were -41.44 million, -41.58% less than in 2023.